Skip to main content
Log in

CD34 immunoreactivity in nervous system tumors

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

CD34 is a sialylated transmembrane glyco-protein of unknown function that is present in myeloid progenitor cells, endothelial cells, and some fibroblastrelated mesenchymal cells. However, its tissue distribution is still incompletely characterized. In this study we evaluated the distribution of CD34 antigen in tumors of the central and peripheral nervous system. For comparison the tumors were also stained for CD31, also known as platelet-endothelium cell adhesion molecule (PECAM-1), a transmembrane glycoprotein so far considered to be endothelium specific beyond its reactivity with certain hematopoietic cells. Neurofibromas showed consistently high numbers of CD34-positive spindle cells, whereas peripheral and acoustic schwannomas were negative. A subset of meningiomas (15%) showed CD34-positive tumor cells, and some were also weakly positive for CD31. Gliomas were negative. Meningeal hemangiopericytomas were consistently CD34 positive, but CD31 negative. These results indicate a moderately widespread distribution of the CD34 antigen in nervous system tumors, and necessitate caution in making conclusions regarding endothelial cell differentiation of nervous system tumors on the basis of CD34 immunoreactivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Albelda SM, Muller WA, Buck CA, Newman PJ (1991) Molecular and cellular properties of PECAM-1 (endoCAM/ CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol 114: 1059–1068

    Article  PubMed  Google Scholar 

  2. Erlandson RA (1991) The enigmatic perineurial cell and its participation in tumors and in tumor-like entities. Ultrastruct Pathol 15: 335–351

    PubMed  Google Scholar 

  3. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75: 2417–2426

    PubMed  Google Scholar 

  4. Hashimoto K, Brownstein MH, Jakobiec FA (1974) Dermatofibrosarcoma protuberans. A tumor with perineural and endoneural cell features. Arch Dermatol 110: 874–885

    Article  PubMed  Google Scholar 

  5. Hewan-Lowe K, Furlong B, Mackay B (1993) Perineurial cell differentiation in benign tumors and tumor-like proliferation of peripheral nerves. Ultrastruct Pathol 17: 263–270

    PubMed  Google Scholar 

  6. Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3: 255–268

    PubMed  Google Scholar 

  7. Miettinen M, Lindenmayer AE, Chaubal A (1994) Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens — evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7: 82–90

    PubMed  Google Scholar 

  8. Newman PJ, Berndt MC, Gorski J, White GC, Lyman S, Paddock C, Muller WA (1990) PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247: 1219–1222

    PubMed  Google Scholar 

  9. Nickoloff BJ (1991) The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 127: 523–529

    Article  PubMed  Google Scholar 

  10. Passivuo R, Saksela E (1983) Non-specific binding of mouse immunoglobulins by swollen-bodied astrocytes: a potential source of confusion in human brain immunohistochemistry. Acta Neuropathol (Berl) 59: 103–108

    Google Scholar 

  11. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY (1990) J70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43: 752–757

    PubMed  Google Scholar 

  12. Russell DS, Rubinstein LJ (1989) Pathology of tumours of the nervous system, 5th edn. Williams & Wilkins, Baltimore

    Google Scholar 

  13. Simmons DL, Walker C, Power C, Pigott R (1990) Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med 171: 2147–2152

    Article  PubMed  Google Scholar 

  14. Stockinger H, Gadd SJ, Eher R, Majdic O, Schreiber W, Kasinsrek W, Strass B, Schnabl E, Knapp W (1990) Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 145: 3889–3897

    PubMed  Google Scholar 

  15. Strauss LC, Rowley SD, La Russa VF, Sharkis SJ, Stuart RK, Civin CI (1986) Antigenic analysis of hematopoiesis. V. Characterization of My10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 14: 878–886

    PubMed  Google Scholar 

  16. Watt SM, Karhi K, Gatter K, et al (1987) Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells. Leukemia 1: 1417–1426

    Google Scholar 

  17. Weiss SW, Nickoloff BJ (1993) CD34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 17: 1039–1045

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaubal, A., Paetau, A., Zoltick, P. et al. CD34 immunoreactivity in nervous system tumors. Acta Neuropathol 88, 454–458 (1994). https://doi.org/10.1007/BF00389498

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00389498

Key words

Navigation